ALDOB
protein-codingaldolase, fructose-bisphosphate B, the group of Aldolases
Gene summary
Fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) is a tetrameric glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Vertebrates have 3 aldolase isozymes which are distinguished by their electrophoretic and catalytic properties. Differences indicate that aldolases A, B, and C are distinct proteins, the products of a family of related 'housekeeping' genes exhibiting developmentally regulated expression of the different isozymes. The developing embryo produces aldolase A, which is produced in even greater amounts in adult muscle where it can be as much as 5% of total cellular protein. In adult liver, kidney and intestine, aldolase A expression is repressed and aldolase B is produced. In brain and other nervous tissue, aldolase A and C are expressed about equally. There is a high degree of homology between aldolase A and C. Defects in ALDOB cause hereditary fructose intolerance. [provided by RefSeq, Dec 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~29.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009249
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009249
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009249
Submitter: ClinGen
*ALDOB* was first reported in relation to autosomal recessive hereditary fructose intolerance in 1988 (Cross et al., PMID: 3383242). Thirteen variants (missense, in-frame indel, nonsense, frameshift, splice), that have been reported in twelve probands in five publications (PMIDs: 3383242, 8071980, 1967768, 18541450, 25595217) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by a knockout mouse model (PMID: 25637246). In summary, there is definitive evidence supporting the relationship between *ALDOB* and autosomal recessive hereditary fructose intolerance. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. UNC and Myriad Women’s Health biocurators contributed to this curation. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date September 4, 2025 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0009249
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009249
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009249
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009249
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009249
Submitter: Myriad Women's Health
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Gastrointestinal; Neurologic; Renal
Intervention: Biochemical; Gastrointestinal
Rationale: Clinical manifestations, which can be severe/fatal, occur with the dietary introduction of fructose or sucrose, and dietary measures (fructose restriction) can be effective
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ALDOB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000035.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 8 | 165 | 174 | ||
| missense | 4 | 17 | 131 | 7 | 159 | |
| nonsense | 16 | 19 | 1 | 36 | ||
| start loss | 4 | 4 | ||||
| frameshift | 16 | 32 | 48 | |||
| splice donor/acceptor (+/-2bp) | 8 | 28 | 2 | 38 | ||
| Total | 44 | 101 | 142 | 172 | 0 | 459 |
Highest pathogenic variant AF is 0.004390486
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000026.2 | 8 | MANE Select | |
| Ensembl | ENSP00000497767.1 | 8 | MANE Select | |
| Ensembl | ENSP00000497990.1 | 8 | Standard | |
| Ensembl | ENSP00000497985.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycolysis / Gluconeogenesis - Homo sapiens (human)
- Fructose and mannose metabolism - Homo sapiens (human)
- Pentose phosphate pathway - Homo sapiens (human)
- Warburg Effect
- Fructose intolerance, hereditary
Biological Process
- fructose metabolic process
- gluconeogenesis
- glycolytic process
- NADH oxidation
- fructose 1,6-bisphosphate metabolic process
Molecular Function
- fructose-bisphosphate aldolase activity
- protein binding
- cytoskeletal protein binding
- identical protein binding
- ATPase binding
Cellular Component
- microtubule organizing center
- cytosol
- centriolar satellite
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000374855
- Coding exons
- 8
- Length
- 15246
- Individuals with no LoFs
- 125680
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 68
- Defined
- 125748
- p
- 0.000270
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.42 | 255 | 199 | 1.28 | 0.0000119 | 2368 |
| Missense (PolyPhen) | 125 | 91.645 | 1.364 | 1024 | ||
| Synonymous | -1.68 | 94 | 75.5 | 1.25 | 0.00000442 | 733 |
| Loss of Function | 1.25 | 12 | 17.7 | 0.679 | 9.59e-7 | 202 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00043 | 0.00044 | rare |
| Finnish | 0.00032 | 0.00032 | rare |
| European (Non-Finnish) | 0.00027 | 0.00027 | rare |
| South Asian | 0.00023 | 0.00023 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Disease
- DISEASE: Hereditary fructose intolerance (HFI) [MIM:229600]: Autosomal recessive disease that results in an inability to metabolize fructose and related sugars. Complete exclusion of fructose results in dramatic recovery; however, if not treated properly, HFI subjects suffer episodes of hypoglycemia, general ill condition, and risk of death the remainder of life. {ECO:0000269|PubMed:10024431, ECO:0000269|PubMed:10970798, ECO:0000269|PubMed:12205126, ECO:0000269|PubMed:15532022, ECO:0000269|PubMed:15880727, ECO:0000269|PubMed:1967768, ECO:0000269|PubMed:20848650, ECO:0000269|PubMed:2336380, ECO:0000269|PubMed:3383242, ECO:0000269|PubMed:8162030, ECO:0000269|PubMed:8299883}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.728
Intolerance Scores
- LoFtool
- 0.133
- RVIS EVS
- 0.06
- RVIS percentile EVS
- 58.74
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.800
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |